Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN), Ocuphire Pharma (OCUP) and Vertex Pharmaceuticals (VRTX)
TipRanksApr 2 07:20 ET
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc
MT NewswiresFeb 29 04:40 ET
Balanced Outlook: Hold Rating Justified for Smith & Nephew Amidst Growth and Market Challenges
TipRanksFeb 28 07:40 ET
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), TELA Bio (TELA) and Smith & Nephew Snats (SNN)
TipRanksDec 1, 2023 08:20 ET
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc
MT NewswiresNov 3, 2023 11:45 ET
Smith & Nephew Analyst Ratings
BenzingaOct 4, 2023 06:53 ET
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
MT NewswiresAug 3, 2023 07:50 ET
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
MT NewswiresApr 27, 2023 03:28 ET
RBC Boosts Price Target on Smith & Nephew to GBP16 From GBP15, Keeps Outperform Rating
MT NewswiresMar 14, 2023 08:12 ET
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
MT NewswiresFeb 21, 2023 23:47 ET
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
MT NewswiresNov 4, 2022 00:32 ET
Credit Suisse Cuts Price Target on Smith & Nephew to GBP14 From GBP15.40, Noting 'Mixed' First-Half Results, 'Major' Margin Pressure; Outperform Kept
MT NewswiresAug 4, 2022 09:20 ET
RBC Cuts Price Target on Smith & Nephew to GBP15 From GBP17, Maintains Outperform Rating
MT NewswiresAug 1, 2022 08:46 ET
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew
MT NewswiresJul 29, 2022 04:08 ET
No Data
No Data